Biosimilars Follow-on-biologics Market

Biosimilars Follow-on-biologics Market aims to provide a comprehensive presentation of the global market for Biosimilars & Follow-on-biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars & Follow-on-biologics. Biosimilars Follow-on-biologics Market contains market size and forecasts of Biosimilars & Follow-on-biologics in global, including the following market information:
Global Biosimilars & Follow-on-biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biosimilars & Follow-on-biologics market was valued at US$ 9560.2 million in 2022 and is projected to reach US$ 11700 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biosimilars or follow-on-biologics are the ?copied? and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process.?
We surveyed the Biosimilars & Follow-on-biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars & Follow-on-biologics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, by Type, 2022 (%)
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Global Biosimilars & Follow-on-biologics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars & Follow-on-biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biosimilars & Follow-on-biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars & Follow-on-biologics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biosimilars & Follow-on-biologics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilars & Follow-on-biologics, market overview.
Chapter 2: Global Biosimilars & Follow-on-biologics market size in revenue.
Chapter 3: Detailed analysis of Biosimilars & Follow-on-biologics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilars & Follow-on-biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.